CENTENE CORPORATION for CENTENE CORPORATION
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to Advance Notice of Methodological Changes for Calendar Year (CY) 2024 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies. Issues related to status of state-based Medicaid redetermination process. Issues related to impact of advance rate notice proposed methodology on Medicare Advantage program. Issues related to the status of Medicaid redetermination/PHE unwinding process. Issues related to Medicare Advantage and educating on the value of the program, and focus on annual Medicare Advantage Congressional support letter Draft legislation titled No Unreasonable Payments, Coding, or Diagnoses for the Elderly (No UPCODE) Act, including provisions relating to altering the Medicare Advantage payment model by requiring the use of two years of diagnostic data instead of one year in calculating health status data, excluding the ability of plans to solely use chart reviews and health risk assessments in calculating adjustments in payment based on health status, and evaluating the coding intensity at the plan or contract level and making adjustments to make it more in-line with the coding intensity for FFS.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER ECKRICH | — |
| JOHN KAELIN | — |
| DANNY LY | — |
| JOSEPH MUSKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.